0001181431-14-022661.txt : 20140623 0001181431-14-022661.hdr.sgml : 20140623 20140604162946 ACCESSION NUMBER: 0001181431-14-022661 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140602 FILED AS OF DATE: 20140604 DATE AS OF CHANGE: 20140604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 650 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 259-1165 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 650 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shively Richard Scott CENTRAL INDEX KEY: 0001438675 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 14891139 MAIL ADDRESS: STREET 1: ALPHARMA PHARMACEUTICALS LLC STREET 2: 440 ROUTE 22 EAST CITY: BRIDGEWATER STATE: NJ ZIP: 08807 4 1 rrd410340.xml FORM 4_RSU DISPOSITION X0306 4 2014-06-02 0 0001375151 ZOGENIX, INC. ZGNX 0001438675 Shively Richard Scott 12400 HIGH BLUFF DRIVE, SUITE 650 SAN DIEGO CA 92130 0 1 0 0 Chief Commercial Officer Common Stock 2014-06-02 2014-06-02 4 S 0 17746 2.1023 D 360254 D Common Stock 2014-06-03 2014-06-03 4 S 0 1464 2.0278 D 358790 D Common Stock 2014-06-03 2014-06-03 4 S 0 19 2.00 D 358771 D This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person to cover the taxes payable upon the vesting of 46,000 restricted stock units on June 1, 2014. Reflects the weighted average sale price of the shares sold. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Reflects the weighted average sale price of the shares sold. These shares were sold in multiple transactions at prices ranging from $2.03 to $2.27. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Thomas Doyle, Attorney-In-Fact 2014-06-04